The effect of individualized patient education, along with emotional support, on the quality of life of breast cancer patients - A pilot study
Document Type
Article
Department
School of Nursing and Midwifery, Pakistan
Abstract
PURPOSE:
This study aimed to determine the effect of individualized patient education along with emotional support on the quality of life (QoL) of breast cancer patients undergoing chemotherapy. It also aimed to determine the intervention's feasibility in the Pakistani context.
METHODS:
A quasi-experimental design, with pre- and post-test, in two groups, via time block, was used. The study was conducted at a public hospital in Karachi with a sample of 50 patients; 25 patients each in the intervention and control group. The intervention was delivered over a period of six weeks. It comprised verbal and written patient education, availability of a nurse during patients' chemotherapy administration and over the telephone, and a telephone follow-up of the patients by the nurse. patients' QoL was assessed at baseline and at the sixth week of receiving chemotherapy.
RESULTS:
Tests indicated a significant improvement in the overall QoL, breast cancer subscale scores, and the physical and emotional well-being of the intervention group, as compared to the control group. The intervention effect size was moderate (0.655) for the QoL.
CONCLUSION:
The intervention was found to be effective in improving patients' QoL. However, a larger study, in a multi-center setting, is recommended to ascertain the findings of this pilot study.
Publication (Name of Journal)
European Journal of Oncology Nursing
Recommended Citation
Sajjad, S.,
Ali, A.,
Gul, R. B.,
Mateen, A.,
Rozi, S.
(2016). The effect of individualized patient education, along with emotional support, on the quality of life of breast cancer patients - A pilot study. European Journal of Oncology Nursing, 21(1), 75-82.
Available at:
https://ecommons.aku.edu/pakistan_fhs_son/283
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.